FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 269 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,196,069 | -32.6% | 118,540 | +49.6% | 0.01% | -28.6% |
| Q3 2022 | $1,775,000 | -27.2% | 79,216 | -19.4% | 0.01% | -22.2% |
| Q2 2022 | $2,437,000 | -17.6% | 98,343 | +29.0% | 0.01% | 0.0% |
| Q1 2022 | $2,957,000 | -1.4% | 76,258 | +48.8% | 0.01% | 0.0% |
| Q4 2021 | $2,998,000 | +5.4% | 51,240 | +6.8% | 0.01% | 0.0% |
| Q3 2021 | $2,845,000 | -32.1% | 47,995 | -0.5% | 0.01% | -35.7% |
| Q2 2021 | $4,187,000 | +16.0% | 48,243 | +10.2% | 0.01% | +7.7% |
| Q1 2021 | $3,609,000 | -11.8% | 43,770 | -2.7% | 0.01% | -7.1% |
| Q4 2020 | $4,092,000 | +57.3% | 45,007 | -30.8% | 0.01% | +40.0% |
| Q3 2020 | $2,601,000 | +13.1% | 65,079 | -2.9% | 0.01% | 0.0% |
| Q2 2020 | $2,299,000 | +38.6% | 67,016 | -37.3% | 0.01% | +66.7% |
| Q3 2019 | $1,659,000 | – | 106,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
| Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
| Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
| Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
| Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
| Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
| Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
| Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
| Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |